$QPRC
QUEST PATENT RESEARCH CORP Stock $qprc

$qprc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086173 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$12.70M	$250.0K	$275.0K
YoY Change	23336.06%	-9.09%
Cost Of Revenue		$56.00K	$33.00K
YoY Change		69.7%
Gross Profit		-$77.76K	$127.6K
YoY Change		-160.94%	-2290.68%
Gross Profit Margin		-31.1%	46.4%
Selling, General & Admin	$518.5K	$598.3K	$476.8K
YoY Change	135.97%	25.48%	31.21%
% of Gross Profit			373.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$195.3K	$202.5K	$198.3K
YoY Change	-1.62%	2.14%	43.01%
% of Gross Profit			155.37%
Operating Expenses	$714.5K	$598.3K	$476.8K
YoY Change	71.04%	25.48%	31.21%
Operating Profit		-$676.1K	-$349.2K
YoY Change		93.6%	-5.42%
Interest Expense	-$472.3K	-$157.2K	$452.9K
YoY Change	700.19%	-134.72%	-193.35%
% of Operating Profit
Other Income/Expense, Net		-$157.2K	$452.9K
YoY Change		-134.72%	-73.76%
Pretax Income	$6.592M	-$833.3K	$103.7K
YoY Change	-1448.75%	-903.83%	-88.11%
Income Tax	$0.00
% Of Pretax Income	0.0%
Net Earnings	$6.592M	-$833.3K	$103.7K
YoY Change	-1488.93%	-903.83%	-88.11%
Net Earnings / Revenue	51.9%	-333.31%	37.7%
Basic Earnings Per Share		-$0.16	$0.02
Diluted Earnings Per Share	$1.24	-$0.16	$0.02
COMMON SHARES
Basic Shares Outstanding	5.332M shares	5.332M shares	5.332M shares
Diluted Shares Outstanding		5.332M shares	5.333M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$563.5K	$611.5K	$75.97K
YoY Change	521.94%	704.88%	-64.48%
Cash & Equivalents	$563.5K	$611.5K	$75.97K
Short-Term Investments
Other Short-Term Assets	$28.12K	$63.07K	$13.09K
YoY Change	428.47%	381.72%	-15.7%
Inventory
Prepaid Expenses
Receivables	$3.008M		$215.6K
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$3.600M	$674.5K	$304.6K
YoY Change	3652.9%	121.43%	32.4%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$3.675M	$3.870M	$1.330M
YoY Change	224.85%	191.04%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.675M	$3.870M	$1.330M
YoY Change	224.85%	191.04%	-25.56%
TOTAL ASSETS
Total Short-Term Assets	$3.600M	$674.5K	$304.6K
Total Long-Term Assets	$3.675M	$3.870M	$1.330M
Total Assets	$7.274M	$4.544M	$1.634M
YoY Change	492.83%	178.07%	-18.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$296.5K	$283.3K	$193.1K
YoY Change	99.65%	46.66%	71.99%
Accrued Expenses	$1.097M	$1.469M	$787.7K
YoY Change	21.27%	86.49%	90.35%
Deferred Revenue
YoY Change
Short-Term Debt	$7.464M	$10.96M	$5.422M
YoY Change	33.49%	102.12%	64.89%
Long-Term Debt Due	$2.797M	$2.797M	$2.804M
YoY Change	0.0%	-0.25%	-0.05%
Total Short-Term Liabilities	$11.94M	$15.81M	$9.410M
YoY Change	24.5%	67.98%	-10.22%
LONG-TERM LIABILITIES
Long-Term Debt	$150.0K	$150.0K	$147.6K
YoY Change	0.0%	1.63%	-1.6%
Other Long-Term Liabilities	$53.67K	$53.67K	$190.0K
YoY Change	0.0%	-71.75%	0.0%
Total Long-Term Liabilities	$203.7K	$203.7K	$337.6K
YoY Change	0.0%	-39.67%	-0.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.94M	$15.81M	$9.410M
Total Long-Term Liabilities	$203.7K	$203.7K	$337.6K
Total Liabilities	$12.14M	$16.01M	$9.748M
YoY Change	24.0%	64.25%	-9.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.54M	-$29.13M	-$25.71M
YoY Change	-13.94%	13.29%
Common Stock	$160.00	$160.00	$160.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.865M	-$11.47M	-$8.114M
YoY Change
Total Liabilities & Shareholders Equity	$7.274M	$4.544M	$1.634M
YoY Change	492.83%	178.07%	-18.94%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	$6.592M	-$833.3K	$103.7K
YoY Change	-1488.93%	-903.83%	-88.11%
Depreciation, Depletion And Amortization	$195.3K	$202.5K	$198.3K
YoY Change	-1.62%	2.14%	43.01%
Cash From Operating Activities	$3.447M	-$418.5K	-$260.2K
YoY Change	-2394.86%	60.86%	77.18%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$30.00K	-$442.0K
YoY Change		-106.79%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$30.00K	-$442.0K
YoY Change		-93.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.495M	931.5K	550.0K
YoY Change	-2220.29%	69.36%	175.0%
NET CHANGE
Cash From Operating Activities	3.447M	-418.5K	-260.2K
Cash From Investing Activities	0.000	-30.00K	-442.0K
Cash From Financing Activities	-3.495M	931.5K	550.0K
Net Change In Cash	-47.98K	483.0K	-152.2K
YoY Change	-427.96%	-417.35%	-386.34%
FREE CASH FLOW
Cash From Operating Activities	$3.447M	-$418.5K	-$260.2K
Capital Expenditures	$0.00	$30.00K	-$442.0K
Free Cash Flow	$3.447M	-$448.5K	$181.8K
YoY Change	-2394.86%	-346.7%	-223.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	33-18099-NY
	dei	Entity Registrant Name EntityRegistrantName	QUEST PATENT RESEARCH CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00003
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2873662
	dei	Entity Address Address Line1 EntityAddressAddressLine1	411 Theodore Fremd Ave
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 206S
	dei	Entity Address City Or Town EntityAddressCityOrTown	Rye
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10580-1411
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	743-7577
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5331973	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	611466	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90601	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	63067	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5321	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	674533	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	95922	usd
CY2023Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	2217106	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1625846	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3869894	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1131154	usd
CY2023Q3	us-gaap	Assets Assets	4544427	usd
CY2022Q4	us-gaap	Assets Assets	1227076	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	283247	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	148533	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10820588	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5453204	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	300000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	145428	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1468925	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	904573	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	15807260	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9586238	usd
CY2023Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	150000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	150000	usd
CY2023Q3	qprc	Purchase Price Of Patents PurchasePriceOfPatents	53665	usd
CY2022Q4	qprc	Purchase Price Of Patents PurchasePriceOfPatents	53665	usd
CY2023Q3	us-gaap	Liabilities Liabilities	16010925	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9789903	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00003
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00003
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00003
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5331973	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5331973	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5331973	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5331973	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	160	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	160	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17664905	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17626279	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29131791	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26189494	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11466726	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8563055	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	228	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	228	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11466498	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8562827	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4544427	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1227076	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	250000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	275000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	452500	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	397000	usd
CY2023Q3	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	327759	usd
CY2022Q3	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	147393	usd
	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	613236	usd
	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	237487	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-77759	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	127607	usd
	us-gaap	Gross Profit GrossProfit	-160736	usd
	us-gaap	Gross Profit GrossProfit	159513	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	598296	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	476812	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2026057	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1561987	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	598296	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	476812	usd
	us-gaap	Operating Expenses OperatingExpenses	2026057	usd
	us-gaap	Operating Expenses OperatingExpenses	1561987	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-676055	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-349205	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2186793	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1402474	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-59480	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-565928	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	154572	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1432145	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-216711	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-113058	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-570932	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-295705	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-157231	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	452870	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-725504	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1136440	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-833286	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103665	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2912297	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-266034	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12884	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-833286	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	103665	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2942297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-278918	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5331973	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5333347	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5331973	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5333347	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7926723	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	42079	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-162640	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8047284	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	24928	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-219943	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8242299	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	25203	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	103665	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8113431	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8562827	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18573	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-939365	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9483619	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9972	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1169646	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10643293	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10081	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-833286	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11466498	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2942297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-278918	usd
	qprc	Change In Fair Market Value Of Warrant Liabilitys ChangeInFairMarketValueOfWarrantLiabilitys	154572	usd
	qprc	Change In Fair Market Value Of Warrant Liabilitys ChangeInFairMarketValueOfWarrantLiabilitys	-1432145	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38626	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	92210	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	591260	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	711826	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	215571	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	564352	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	295705	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	134714	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	63709	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	57746	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	787	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1516520	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-763971	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3330000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1502000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3330000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1502000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-3850	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	5500000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2103000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	132616	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	22051	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5367385	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2077099	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	520865	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-188872	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90601	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	264840	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	611466	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75968	usd
	qprc	Interest Added To Principal InterestAddedToPrincipal	4208	usd
	qprc	Interest Added To Principal InterestAddedToPrincipal	4208	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12884	usd
	us-gaap	Interest Paid Net InterestPaidNet	6579	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30000	usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12884	usd
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	effected a one-for-100 reverse split
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Revenue Recognition</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Patent Licensing Fees</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers”. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the periods presented, revenue contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company’s operating subsidiaries as part of the settlement of litigation commenced by the Company’s subsidiaries. Intellectual property rights granted included the following, as applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted were perpetual in nature, extending until the legal expiration date of the related patents. The individual intellectual property rights are not accounted for as separate performance obligations, as (a) the nature of the promise, within the context of the contract, is to transfer combined items to which the promised intellectual property rights are inputs and (b) the Company’s promise to transfer each individual intellectual property right described above to the customer is not separately identifiable from other promises to transfer intellectual property rights in the contract.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the promised intellectual property rights are not individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted for all of the intellectual property rights promised in the contract as a single performance obligation. The intellectual property rights granted were “functional IP rights” that have significant standalone functionality. The Company’s subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. The Company’s subsidiaries have no further obligation with respect to the grant of intellectual property rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support or services. The contracts provide for the grant (i.e., transfer of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally obtain control of the intellectual property rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for payment of contractual amounts within 30 to 90 days of execution of the contract. Contractual payments made by licensees are generally non-refundable. The Company does not have any significant payment terms, as payment is received shortly after goods are delivered or services are provided, therefore there is no significant financing component or consideration payable to the customer in these transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentration of Credit Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its cash in bank deposit accounts, which at times, may exceed federally insured limits. The Company has not experienced any such losses in these accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	qprc	Warrants Granted WarrantsGranted	962463	shares
	qprc	Purchase Agreement Stock Options PurchaseAgreementStockOptions	500000	shares
	qprc	Stock Options Granted To Officers And Consultant StockOptionsGrantedToOfficersAndConsultant	600000	shares
CY2023Q3	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	29132000	usd
	qprc	Negative Working Capital NegativeWorkingCapital	15133000	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2023Q3	qprc	Funding Liability Qfl FundingLiabilityQFL	5520588	usd
CY2022Q4	qprc	Funding Liability Qfl FundingLiabilityQFL	5453204	usd
CY2023Q3	qprc	Funding Liability Qf3 FundingLiabilityQF3	5300000	usd
CY2023Q3	qprc	Net Funding Liabilities NetFundingLiabilities	10820588	usd
CY2022Q4	qprc	Net Funding Liabilities NetFundingLiabilities	5453204	usd
CY2023Q3	us-gaap	Obligation With Joint And Several Liability Arrangement Amount Outstanding ObligationWithJointAndSeveralLiabilityArrangementAmountOutstanding	5520588	usd
CY2022Q4	us-gaap	Obligation With Joint And Several Liability Arrangement Amount Outstanding ObligationWithJointAndSeveralLiabilityArrangementAmountOutstanding	5453204	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	882000	usd
	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	133000	usd
CY2023Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	961000	usd
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	600000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	962463	shares
CY2023Q3	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0.10	pure
CY2022Q2	qprc	Purchase Agreement PurchaseAgreement	92000	usd
CY2022Q3	qprc	Purchase Price Percentage PurchasePricePercentage	0.50	pure
CY2022Q3	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	350000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	35000	usd
CY2023Q3	qprc	Operating Capital Advance OperatingCapitalAdvance	0	usd
	qprc	Operating Capital Advance OperatingCapitalAdvance	200000	usd
CY2022Q3	qprc	Operating Capital Advance OperatingCapitalAdvance	200000	usd
	qprc	Operating Capital Advance OperatingCapitalAdvance	600000	usd
CY2022Q3	qprc	Funding Liability fundingLiability	190000	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4000000	usd
	qprc	Requested And Received RequestedAndReceived	2000000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	3300000	usd
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	25000000	usd
CY2023Q1	qprc	Proceeds From Finance ProceedsFromFinance	3300000	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2796500	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2796500	usd
CY2015Q4	qprc	Purchase Agreement PurchaseAgreement	4672810	usd
	us-gaap	Notes Issued1 NotesIssued1	250000	usd
	qprc	Loss On Debt Conversion LossOnDebtConversion	305556	usd
	qprc	Asset Acquired Description AssetAcquiredDescription	Pursuant to the MPA-NA, until the TMPO has been paid in full, Intelligent Partners is entitled to receive 10% of the net proceeds realized from new assets acquired by the Company. If, in any calendar quarter, net proceeds realized exceed $1,000,000, Intelligent Partners’ entitlement for that quarter only shall increase to 30% on the portion of net proceeds in excess of $1,000,000 but less than $3,000,000. If in the same calendar quarter, net proceeds exceed $3,000,000, Intelligent Partners’ entitlement for that quarter only shall increase to 50% on the portion of net proceeds in excess of $3,000,000.
	qprc	Payments For Loan PaymentsForLoan	275000	usd
	qprc	Obligation Excess ObligationExcess	1000000	usd
	us-gaap	Derivative Maturity Dates DerivativeMaturityDates	2050-05-14
	qprc	Deducted Loan Amount DeductedLoanAmount	100	usd
	qprc	Loan Origination Cost loanOriginationCost	1000	usd
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	53665	usd
CY2022	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	53665	usd
CY2020Q2	qprc	Acquisition Funding AcquisitionFunding	95000	usd
	qprc	Funder Received FunderReceived	53665	usd
CY2021Q1	us-gaap	Shares Issued SharesIssued	962463	shares
CY2021Q1	qprc	Warrant Yield Percentage WarrantYieldPercentage	0.10	pure
CY2021Q1	qprc	Aggregate Number Of Outstanding Shares AggregateNumberOfOutstandingShares	0.10	pure
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	300000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	145000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.96	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.74	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.54
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y4M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P8Y1M6D
CY2022Q4	qprc	Warrant Liability WarrantLiability	145428	usd
CY2023Q1	qprc	Gain On Subsequent Measurement GainOnSubsequentMeasurement	8566	usd
CY2023Q1	qprc	Warrant Liability WarrantLiability	153994	usd
CY2023Q2	qprc	Gain On Subsequent Measurement GainOnSubsequentMeasurement	205486	usd
CY2023Q2	qprc	Warrant Liability WarrantLiability	359480	usd
CY2023Q3	qprc	Gain On Subsequent Measurementin Dollars GainOnSubsequentMeasurementinDollars	-59480	usd
CY2023Q3	qprc	Warrant Liability WarrantLiability	300000	usd
CY2021Q4	qprc	Warrant Liability WarrantLiability	1636187	usd
CY2022Q1	qprc	Gain On Subsequent Measurementin Dollars GainOnSubsequentMeasurementinDollars	-471607	usd
CY2022Q1	qprc	Warrant Liability WarrantLiability	1164580	usd
CY2022Q2	qprc	Gain On Subsequent Measurementin Dollars GainOnSubsequentMeasurementinDollars	-394610	usd
CY2022Q2	qprc	Warrant Liability WarrantLiability	769970	usd
CY2022Q3	qprc	Gain On Subsequent Measurementin Dollars GainOnSubsequentMeasurementinDollars	-565928	usd
CY2022Q3	qprc	Warrant Liability WarrantLiability	204042	usd
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	effected a one-for-100 reverse split
CY2022Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	0.01	shares
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2217106	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1625846	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3869894	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1131154	usd
	qprc	Weighted Average Amortization Period Years WeightedAverageAmortizationPeriodYears	P5Y8M8D
CY2022	qprc	Weighted Average Amortization Period Years WeightedAverageAmortizationPeriodYears	P2Y5M23D
CY2020Q2	qprc	Purchase Price PurchasePrice	95000	usd
CY2020Q2	qprc	Net Proceeds NetProceeds	230000	usd
CY2020Q2	qprc	Net Proceeds Percentage NetProceedsPercentage	0.50	pure
CY2021Q1	qprc	Purchase Price PurchasePrice	350000	usd
CY2021Q1	qprc	Gross Proceeds GrossProceeds	350000	usd
CY2021Q1	qprc	Aggregate Amount AggregateAmount	93900	usd
CY2021Q2	qprc	Purchase Price PurchasePrice	250000	usd
CY2021Q4	qprc	Purchase Price PurchasePrice	550000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y
CY2022Q1	qprc	Purchase Price PurchasePrice	1060000	usd
CY2022Q3	qprc	Purchase Price PurchasePrice	92000	usd
CY2023Q1	qprc	Purchase Price PurchasePrice	3300000	usd
CY2023Q3	qprc	Purchase Price PurchasePrice	30000	usd
CY2023Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	203000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	591000	usd
CY2022Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	198000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	712000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	195291	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	636353	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	540589	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	500064	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	464786	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	1532810	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3869894	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	56000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	118000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	61000	usd
CY2016Q3	qprc	Annual Bonus Compensation Equal Percentage AnnualBonusCompensationEqualPercentage	0.30	pure
CY2016Q3	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	500000	usd
CY2023Q3	us-gaap	Deposits Deposits	33000	usd
CY2022Q3	us-gaap	Deposits Deposits	14500	usd
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0.01
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q4	qprc	Funding Liability Qf3 FundingLiabilityQF3		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000824416

Files In Submission

Name	View Source	Status
f10q0923_questpatent_htm.xml	Edgar Link	completed
0001213900-23-086173-index-headers.html	Edgar Link	pending
0001213900-23-086173-index.html	Edgar Link	pending
0001213900-23-086173.txt	Edgar Link	pending
0001213900-23-086173-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_questpatent.htm	Edgar Link	pending
f10q0923ex32-1_questpatent.htm	Edgar Link	pending
f10q0923_questpatent.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qprc-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qprc-20230930_cal.xml	Edgar Link	unprocessable
qprc-20230930_def.xml	Edgar Link	unprocessable
qprc-20230930_lab.xml	Edgar Link	unprocessable
qprc-20230930_pre.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QPRC
QUEST PATENT RESEARCH CORP Stock $qprc

2023 Q4 Form 10-Q Financial Statement

#000121390023086173 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QPRC QUEST PATENT RESEARCH CORP Stock $qprc

2023 Q4 Form 10-Q Financial Statement

#000121390023086173 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QPRC
QUEST PATENT RESEARCH CORP Stock $qprc